TOGETHER, WE WILL END PANCREATIC CANCER. Trademark

Trademark Overview

On Thursday, February 14, 2013, a trademark application was filed for TOGETHER, WE WILL END PANCREATIC CANCER. with the United States Patent and Trademark Office. The USPTO has given the TOGETHER, WE WILL END PANCREATIC CANCER. trademark a serial number of 85850000. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, October 13, 2021. This trademark is owned by The Translational Genomics Research Institute. The TOGETHER, WE WILL END PANCREATIC CANCER. trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of pancreatic cancer research and treatment

Medical research and medical research support services, namely, recruitment of patients and subjects for various studies collecting and analyzing clinical samples, storing and analyzing clinical data, and DNA sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics
together, we will end pancreatic cancer.

General Information

Serial Number85850000
Word MarkTOGETHER, WE WILL END PANCREATIC CANCER.
Filing DateThursday, February 14, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, October 13, 2021
Registration Number4769113
Registration DateTuesday, July 7, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPromoting collaboration within the scientific, research and medical communities to achieve advances in the field of pancreatic cancer research and treatment
NOT AVAILABLE"PANCREATIC CANCER"
Goods and ServicesMedical research and medical research support services, namely, recruitment of patients and subjects for various studies collecting and analyzing clinical samples, storing and analyzing clinical data, and DNA sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2013
Primary Code035
First Use Anywhere DateThursday, March 26, 2015
First Use In Commerce DateThursday, March 26, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2013
Primary Code042
First Use Anywhere DateThursday, March 26, 2015
First Use In Commerce DateThursday, March 26, 2015

Trademark Owner History

Party NameThe Translational Genomics Research Institute
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85004
Party NameThe Translational Genomics Research Institute
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85004
Party NameThe Translational Genomics Research Institute
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhoenix, AZ 85004

Trademark Events

Event DateEvent Description
Wednesday, May 29, 2013ASSIGNED TO EXAMINER
Wednesday, July 10, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 10, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 5, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 5, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 7, 2013TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, February 18, 2013NEW APPLICATION ENTERED
Thursday, February 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 29, 2013NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2013NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2013WITHDRAWAL OF ATTORNEY GRANTED
Monday, December 16, 2013ASSIGNED TO LIE
Tuesday, November 19, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 2015SOU TEAS EXTENSION RECEIVED
Monday, December 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 16, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, September 16, 2014SOU EXTENSION 1 FILED
Tuesday, September 16, 2014SOU EXTENSION 1 GRANTED
Thursday, September 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2015USE AMENDMENT FILED
Sunday, May 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, May 10, 2015STATEMENT OF USE PROCESSING COMPLETE
Saturday, May 30, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 7, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 15, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 9, 2015SOU EXTENSION 2 FILED
Friday, April 3, 2015SOU EXTENSION 2 GRANTED
Monday, April 6, 2015TEAS STATEMENT OF USE RECEIVED
Friday, May 29, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 2, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 13, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 13, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 13, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, July 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

cancer pancreatic will together research medical clinical analyzing samples storing studies collecting various sequencing